Evidence map›Paper›PMID 26473364›Full record

ArticlePLoS pathogens2015

Shigella Effector OspB Activates mTORC1 in a Manner That Depends on IQGAP1 and Promotes Cell Proliferation.

Richard Lu, Bobby Brooke Herrera, Heather D Eshleman, Yang Fu, Alexander Bloom, Zhigang Li, David B Sacks, Marcia B Goldberg

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. mBio · 2025
    Article
  3. Autophagy and Bacterial infections.Autophagy reports · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. ThemBio · 2022
    Article
  9. Review
  10. SepA EnhancesmBio · 2021
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Microbiology spectrum · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Richard LuDepartment of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Cambridge, Massachusetts, United States of America; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Bobby Brooke HerreraDepartment of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Cambridge, Massachusetts, United States of America.
Heather D EshlemanDepartment of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Cambridge, Massachusetts, United States of America; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Yang FuDepartment of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Cambridge, Massachusetts, United States of America.
Alexander BloomDepartment of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Cambridge, Massachusetts, United States of America.
Zhigang LiDepartment of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland, United States of America.
David B SacksDepartment of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland, United States of America.
Marcia B GoldbergDepartment of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Cambridge, Massachusetts, United States of America; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Massachusetts General Hospital · USNational Institutes of Health · USHarvard University · US

Funding

Treatments for Nipah Virus InfectionU54AI057159 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WHELAN, SEAN PJ · 2003 to 2013
$113.7M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Molecular signaling in Shigella disseminationR01AI081724 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 2010 to 2026
$7.1M
Genome-wide analysis of host factors required for Shigella spreadF32AI073035 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LU, RICHARD · 2007 to 2008
$101k
IQGAP1 in tumorigenesisZIACL080017 · CLC · CLINICAL CENTER · PI SACKS, DAVID · 2012 to 2025
$0k
Intramural NIH HHSNIAID NIH HHS F32 AI073035NIAID NIH HHS F32AI073035NIAID NIH HHS R01 AI081724NIAID NIH HHS R01AI081724NIAID NIH HHS T32 AI007061NIAID NIH HHS U54 AI057159NIAID NIH HHS U54AI057159
6 · The paper itself

Abstract

The intracellular bacterial pathogen Shigella infects and spreads through the human intestinal epithelium. Effector proteins delivered by Shigella into cells promote infection by modulating diverse host functions. We demonstrate that the effector protein OspB interacts directly with the scaffolding protein IQGAP1, and that the absence of either OspB or IQGAP1 during infection leads to larger areas of S. flexneri spread through cell monolayers. We show that the effect on the area of bacterial spread is due to OspB triggering increased cell proliferation at the periphery of infected foci, thereby replacing some of the cells that die within infected foci and restricting the area of bacterial spread. We demonstrate that OspB enhancement of cell proliferation results from activation of mTORC1, a master regulator of cell growth, and is blocked by the mTORC1-specific inhibitor rapamycin. OspB activation of mTORC1, and its effects on cell proliferation and bacterial spread, depends on IQGAP1. Our results identify OspB as a regulator of mTORC1 and mTORC1-dependent cell proliferation early during S. flexneri infection and establish a role for IQGAP1 in mTORC1 signaling. They also raise the possibility that IQGAP1 serves as a scaffold for the assembly of an OspB-mTORC1 signaling complex.

Indexed as

Bacterial Outer Membrane ProteinsBlotting, WesternCell LineCell ProliferationDysentery, BacillaryHumansMechanistic Target of Rapamycin Complex 1Multiprotein Complexesras GTPase-Activating ProteinsRNA, Small InterferingShigella flexneriTOR Serine-Threonine KinasesTransfectionBacterial Outer Membrane ProteinsIQ motif containing GTPase activating protein 1Mechanistic Target of Rapamycin Complex 1Multiprotein Complexesras GTPase-Activating ProteinsRNA, Small InterferingTOR Serine-Threonine Kinases

Identifiers

PMID26473364
PMCPMC4608727
OpenAlexW2109839611

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.